LYZ and tuberculosis: In addition, while both TB-IRIS patients and HIV+TB+ controls showed decreasing levels of anti-lysozyme during follow-up, TB-IRIS patients showed a stronger decrease in anti-lactoferrin, whereas HIV+TB+ controls showed a decrease in anti-MPO and -elastase.